ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient-Level Analysis of Multiple Randomized Trials (SEAL).

Qian Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.